Your browser doesn't support javascript.
loading
Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade.
Yadavilli, Sapna; Waight, Jeremy D; Brett, Sara; Bi, Meixia; Zhang, Tianqian; Liu, Yao-Bin; Ellis, Catherine; Turner, David C; Hahn, Ashleigh; Shi, Hong; Seestaller-Wehr, Laura; Jing, Junping; Xie, Qing; Shaik, Jafar Sadik; Ji, Xiao; Gagnon, Robert; Fieles, William; Hook, Laura; Grant, Steven; Hopley, Stephanie; DeYoung, M Phillip; Blackwell, Christina; Chisamore, Michael; Biddlecombe, Robert; Figueroa, David J; Hopson, Christopher B; Srinivasan, Roopa; Smothers, James; Maio, Michele; Rischin, Danny; Olive, Daniel; Paul, Elaine; Mayes, Patrick A; Hoos, Axel; Ballas, Marc.
Afiliación
  • Yadavilli S; GSK, Collegeville, Pennsylvania.
  • Waight JD; GSK, Collegeville, Pennsylvania.
  • Brett S; GSK, Stevenage, Hertfordshire, United Kingdom.
  • Bi M; GSK, Collegeville, Pennsylvania.
  • Zhang T; GSK, Collegeville, Pennsylvania.
  • Liu YB; GSK, Collegeville, Pennsylvania.
  • Ellis C; GSK, Collegeville, Pennsylvania.
  • Turner DC; GSK, Collegeville, Pennsylvania.
  • Hahn A; GSK, Collegeville, Pennsylvania.
  • Shi H; GSK, Collegeville, Pennsylvania.
  • Seestaller-Wehr L; GSK, Collegeville, Pennsylvania.
  • Jing J; GSK, Collegeville, Pennsylvania.
  • Xie Q; GSK, Collegeville, Pennsylvania.
  • Shaik JS; GSK, Collegeville, Pennsylvania.
  • Ji X; GSK, Collegeville, Pennsylvania.
  • Gagnon R; GSK, Collegeville, Pennsylvania.
  • Fieles W; GSK, Collegeville, Pennsylvania.
  • Hook L; GSK, Stevenage, Hertfordshire, United Kingdom.
  • Grant S; GSK, Stevenage, Hertfordshire, United Kingdom.
  • Hopley S; GSK, Collegeville, Pennsylvania.
  • DeYoung MP; GSK, Collegeville, Pennsylvania.
  • Blackwell C; GSK, Collegeville, Pennsylvania.
  • Chisamore M; Merck & Co., Inc., Rahway, New Jersey.
  • Biddlecombe R; GSK, Stevenage, Hertfordshire, United Kingdom.
  • Figueroa DJ; GSK, Collegeville, Pennsylvania.
  • Hopson CB; GSK, Collegeville, Pennsylvania.
  • Srinivasan R; GSK, Collegeville, Pennsylvania.
  • Smothers J; GSK, Collegeville, Pennsylvania.
  • Maio M; University of Siena and Center for Immuno-Oncology, Azienda Ospedaliera Universitaria Senese, Siena, Italy.
  • Rischin D; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Olive D; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.
  • Paul E; CRCM, Immunity and Cancer, Inserm, U1068, Institut Paoli-Calmettes, Aix-Marseille Université, UM105, CNRS, UMR7258, Marseille, France.
  • Mayes PA; GSK, Collegeville, Pennsylvania.
  • Hoos A; GSK, Collegeville, Pennsylvania.
  • Ballas M; GSK, Collegeville, Pennsylvania.
Cancer Res Commun ; 3(8): 1564-1579, 2023 08.
Article en En | MEDLINE | ID: mdl-37593752
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Instituciones de Atención Ambulatoria / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials Límite: Animals / Humans Idioma: En Revista: Cancer Res Commun Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Instituciones de Atención Ambulatoria / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials Límite: Animals / Humans Idioma: En Revista: Cancer Res Commun Año: 2023 Tipo del documento: Article